There were a couple of reasons for the sharp decline. First, the post-election rally fizzled to a large extent late last week ...

Other drug manufacturers declined in the days following the nomination. Pfizer and Moderna have declined 6.9% and 6.2% ...

Berenberg has initiated coverage of BioNTech (BNTX) and Moderna (MRNA), citing their leadership positions in mRNA medicine.

Berenberg analyst Harry Gillis initiated coverage of Moderna (MRNA) with a Hold rating and $42 price target. The firm says mRNA will ...

Surprisingly, those who had taken the Moderna vaccine also reported a significantly higher level of anti-S1 than the ...

HSBC analyst Yifeng Liu upgraded Moderna (MRNA) to Buy from Hold with a price target of $58, down from $82. The recent share ...

Levi & Korsinsky, LLP notifies investors in Metagenomi, Inc. ("Metagenomi" or the "Company") of a class action securities ...

Leerink Partners analyst Mani Foroohar has reiterated their bearish stance on MRNA stock, giving a Sell rating on November 14.Don't Miss our ...

Politics will matter greatly for the biotechnology and healthcare sectors. On Thursday, President-elect <a target=_blank ...

It started as a minor disagreement. Since then, Supervisor Belia Ramos, in her first in-depth interview on the subject, says ...

Articles No injuries in vehicle vs. shrubs accident in front of Temple restaurant Brenda Kay Pennington Coley, age 74, of ...